Correction: Dual-responsive nanoparticles targeting ACE-II senescence for therapeutic mitigation of acute lung injury Authors: Linlin Gao, Fushuang Zheng, Zhiling Fu, Wei Wang Published: 2025 Correction: Journal of Nanobiotechnology (2025) 23:339 10.1186/s12951-025-03382-2 In this article Figs 1 and 2 appeared incorrectly and have now been corrected in the original publication. For completeness and transparency, the correct and incorrect versions are displayed below. After further internal verification and repeated experiments, the authors confirmed that the previously published TEM images were mistakenly taken from incorrect archived files due to a technical error in laboratory’s data management system. The authors sincerely apologize for the inconvenience caused. Incorrect Fig. 1 Characterization of NPs and Hydrolytic Behavior under Different Conditions. Note: (A) TEM images of MCD NPs, PCD NPs, and DCD NPs with scalebars set at 200 nm; (B) Size distribution curves of MCD NPs, PCD NPs, and DCD NPs; (C) Zeta potential values of MCD NPs, PCD NPs, and DCD NPs; (D) Averagehydrodynamic diameter of MCD NPs, PCD NPs, and DCD NPs; (E) Changes in average hydrodynamic diameter of DCD NPs before and after cultivationin different solutions for varying durations; (F) Zeta potential values of GNPs; (G) Average hydrodynamic diameter of GNPs; (H) In vitro release profilesof GNPs in PBS solutions at pH 5, pH 6, or pH 7.4 (with or without 1 mM H2O2). Data are presented as mean ± SD, with the experiment repeated 3 times Correct Fig. 1 Characterization of NPs and Hydrolytic Behavior under Different Conditions. Note: (A) TEM images of MCD NPs, PCD NPs, and DCD NPs with scalebars set at 200 nm; (B) Size distribution curves of MCD NPs, PCD NPs, and DCD NPs; (C) Zeta potential values of MCD NPs, PCD NPs, and DCD NPs; (D) Averagehydrodynamic diameter of MCD NPs, PCD NPs, and DCD NPs; (E) Changes in average hydrodynamic diameter of DCD NPs before and after cultivationin different solutions for varying durations; (F) Zeta potential values of GNPs; (G) Average hydrodynamic diameter of GNPs; (H) In vitro release profilesof GNPs in PBS solutions at pH 5, pH 6, or pH 7.4 (with or without 1 mM H2O2). Data are presented as mean ± SD, with the experiment repeated 3 times Incorrect Fig. 2 Validation of In Vitro and In Vivo Targeting of NPs. Note: (A) Schematic illustration of GNPsanti−SP−C synthesis; (B-D) TEM (B), SEM (C), and size distribution(D) of GNPsanti−SP−C, Scale bars = 200 nm; (E) Immunofluorescence detection of NPs uptake by MLE12 cells after incubation with different doses ofCy5/GNPsanti−SP−C for 6 h, Scale bars = 50 μm, Cy5: red; DAPI: blue; (F) Flow cytometric quantification of NPs internalization by MLE12 cells after incubationwith different doses of Cy5/GNPsanti−SP−C for 6 h; (G) Immunofluorescence detection of NPs uptake by MLE12 cells after incubation with 20 μg/mL of Cy5/GNPsanti−SP−C for different time periods, Scale bars = 50 μm, Cy5: red; DAPI: blue; (H) Flow cytometric quantification of NPs internalization by MLE12 cellsafter incubation with 20 μg/mL of Cy5/GNPsanti−SP−C for different time periods; (I) Immunofluorescence detection of NPs uptake by MLE12 cells after incubationwith Cy5/GNPsanti−SP−C and Cy5/GNPs for 6 h, Scale bars = 50 μm, Cy5: red; DAPI: blue; (J) Immunofluorescence detection of co-localization of NPsin lung tissue with ACE-II cell marker ABCA3, Scale bars = 20 μm, n = 3. Cy5: red; DAPI: blue; ABCA3: green. In panels E-H, ** indicates p < 0.01 compared tocontrol (0 μg/mL or 0 h), and *** indicates p < 0.001 compared to control (0 μg/mL or 0 h); In panel I, ** indicates p < 0.01 compared to Cy5/GNPs; In panelJ, ** indicates p < 0.01 compared to Cy5/GNPs group. Cell experiments were repeated three times Correct Fig. 2 Validation of In Vitro and In Vivo Targeting of NPs. Note: (A) Schematic illustration of GNPsanti−SP−C synthesis; (B-D) TEM (B), SEM (C), and size distribution(D) of GNPsanti−SP−C, Scale bars = 200 nm; (E) Immunofluorescence detection of NPs uptake by MLE12 cells after incubation with different doses ofCy5/GNPsanti−SP−C for 6 h, Scale bars = 50 μm, Cy5: red; DAPI: blue; (F) Flow cytometric quantification of NPs internalization by MLE12 cells after incubationwith different doses of Cy5/GNPsanti−SP−C for 6 h; (G) Immunofluorescence detection of NPs uptake by MLE12 cells after incubation with 20 μg/mL of Cy5/GNPsanti−SP−C for different time periods, Scale bars = 50 μm, Cy5: red; DAPI: blue; (H) Flow cytometric quantification of NPs internalization by MLE12 cellsafter incubation with 20 μg/mL of Cy5/GNPsanti−SP−C for different time periods; (I) Immunofluorescence detection of NPs uptake by MLE12 cells after incubationwith Cy5/GNPsanti−SP−C and Cy5/GNPs for 6 h, Scale bars = 50 μm, Cy5: red; DAPI: blue; (J) Immunofluorescence detection of co-localization of NPsin lung tissue with ACE-II cell marker ABCA3, Scale bars = 20 μm, n = 3. Cy5: red; DAPI: blue; ABCA3: green. In panels E-H, ** indicates p < 0.01 compared tocontrol (0 μg/mL or 0 h), and *** indicates p < 0.001 compared to control (0 μg/mL or 0 h); In panel I, ** indicates p < 0.01 compared to Cy5/GNPs; In panelJ, ** indicates p < 0.01 compared to Cy5/GNPs group. Cell experiments were repeated three times The original article has been corrected. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Linlin Gao and Fushuang Zheng are regarded as co-first authors. Contributor Information Zhiling Fu, Email: 20052131@cmu.edu.cn. Wei Wang, Email: 20132219@cmu.edu.cn.